BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sansome DJ, Xie C, Veedfald S, Horowitz M, Rayner CK, Wu T. Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids. Diabetes Obes Metab 2020;22:141-8. [PMID: 31468642 DOI: 10.1111/dom.13869] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Kurtz R, Steinberg LG, Betcher M, Fowler D, Shepard BD. The Sensing Liver: Localization and Ligands for Hepatic Murine Olfactory and Taste Receptors. Front Physiol 2020;11:574082. [PMID: 33123030 DOI: 10.3389/fphys.2020.574082] [Reference Citation Analysis]
2 Chen Y, Wang M. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes. Drug Des Devel Ther 2021;15:4849-63. [PMID: 34876807 DOI: 10.2147/DDDT.S334325] [Reference Citation Analysis]
3 Díaz-Perdigones CM, Muñoz-Garach A, Álvarez-Bermúdez MD, Moreno-Indias I, Tinahones FJ. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients. Biomed Pharmacother 2022;145:112448. [PMID: 34844104 DOI: 10.1016/j.biopha.2021.112448] [Reference Citation Analysis]
4 Borg MJ, Rayner CK, Jones KL, Horowitz M, Xie C, Wu T. Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin. Pharmaceuticals (Basel) 2020;13:E410. [PMID: 33266396 DOI: 10.3390/ph13110410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Guo Z, Priefer R. Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview. Diabetes Metab Syndr 2021;15:102239. [PMID: 34371302 DOI: 10.1016/j.dsx.2021.102239] [Reference Citation Analysis]
6 Bravard A, Gérard C, Defois C, Benoit B, Makki K, Meugnier E, Rainteau D, Rieusset J, Godet M, Vidal H. Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice. Sci Rep 2021;11:16684. [PMID: 34404817 DOI: 10.1038/s41598-021-95117-0] [Reference Citation Analysis]
7 Lee CB, Chae SU, Jo SJ, Jerng UM, Bae SK. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus. Int J Mol Sci 2021;22:3566. [PMID: 33808194 DOI: 10.3390/ijms22073566] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Therdtatha P, Song Y, Tanaka M, Mariyatun M, Almunifah M, Manurung NEP, Indriarsih S, Lu Y, Nagata K, Fukami K, Ikeda T, Lee YK, Rahayu ES, Nakayama J. Gut Microbiome of Indonesian Adults Associated with Obesity and Type 2 Diabetes: A Cross-Sectional Study in an Asian City, Yogyakarta. Microorganisms 2021;9:897. [PMID: 33922321 DOI: 10.3390/microorganisms9050897] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Xie C, Huang W, Young RL, Jones KL, Horowitz M, Rayner CK, Wu T. Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease. Nutrients 2021;13:1104. [PMID: 33800566 DOI: 10.3390/nu13041104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chung MY, Choi HK, Hwang JT. AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals. Nutrients 2021;13:4050. [PMID: 34836306 DOI: 10.3390/nu13114050] [Reference Citation Analysis]
11 Zeng Z, Huang SY, Sun T. Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes. Diabetes Ther 2020;11:2521-38. [PMID: 32930968 DOI: 10.1007/s13300-020-00922-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Han L, Yang HY, Zheng YJ, Wei XX, Dan WC, Zhang LL, Ding QY, Ma X, Wang XM, Zhao LH, Tong XL. Mechanism exploration of Gouqi-wentang formula against type 2 diabetes mellitus by phytochemistry and network pharmacology-based analysis and biological validation. Chin Med 2021;16:93. [PMID: 34579756 DOI: 10.1186/s13020-021-00479-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cheng L, Chen T, Guo M, Liu P, Qiao X, Wei Y, She J, Li B, Xi W, Zhou J, Yuan Z, Wu Y, Liu J. Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress. Clin Sci (Lond) 2021;135:1689-706. [PMID: 34236076 DOI: 10.1042/CS20210198] [Reference Citation Analysis]
14 Delgado GE, Krämer BK, Scharnagl H, Fauler G, Stojakovic T, März W, Kleber ME, Lammert A. Bile Acids in Patients with Uncontrolled Type 2 Diabetes Mellitus - The Effect of Two Days of Oatmeal Treatment. Exp Clin Endocrinol Diabetes 2020;128:624-30. [PMID: 31896155 DOI: 10.1055/a-1069-7330] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhang HY, Tian JX, Lian FM, Li M, Liu WK, Zhen Z, Liao JQ, Tong XL. Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota. Biomed Pharmacother 2021;133:110857. [PMID: 33197760 DOI: 10.1016/j.biopha.2020.110857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sicras-Mainar A, Sicras-Navarro A. [Treatment persistence with brand-name vs. generic metformin in monotherapy for type 2 diabetes: real-life retrospective study using the propensity matching score]. Semergen 2021;47:321-31. [PMID: 34049795 DOI: 10.1016/j.semerg.2020.12.010] [Reference Citation Analysis]
17 Gökçay Canpolat A, Şahin M. Glucose Lowering Treatment Modalities of Type 2 Diabetes Mellitus. Adv Exp Med Biol 2021;1307:7-27. [PMID: 32200500 DOI: 10.1007/5584_2020_516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Roy A, Sahoo J. Long-term effects of metformin use in gestational diabetes mellitus on offspring health. World J Diabetes 2021; 12(11): 1812-1817 [PMID: 34888009 DOI: 10.4239/wjd.v12.i11.1812] [Reference Citation Analysis]
19 Kawanami D, Takashi Y, Tanabe M. Significance of Metformin Use in Diabetic Kidney Disease. Int J Mol Sci 2020;21:E4239. [PMID: 32545901 DOI: 10.3390/ijms21124239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Sansome DJ, Jones KL, Horowitz M, Rayner CK, Wu T. Statins and glycaemic control in type 2 diabetes: Are bile acids relevant? Br J Clin Pharmacol 2020;86:2538-9. [PMID: 32232884 DOI: 10.1111/bcp.14274] [Reference Citation Analysis]
21 Zheng Y, Ding Q, Wei Y, Gou X, Tian J, Li M, Tong X. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis. Phytomedicine 2021;88:153455. [PMID: 33478831 DOI: 10.1016/j.phymed.2020.153455] [Cited by in F6Publishing: 1] [Reference Citation Analysis]